IDCP has been associated with BRCA2 defects in familial prostate cancer, as it was shown that intraductal growth was significantly more prevalent in xenografts from BRCA2-mutated cases than in sporadic cases [31]. This evidence concerns the gene BRCA2 and prostate cancer, hereditary.